Key facts
as of Oct 2026- Manufacturer of degradable, implantable medical devices made from novel photopolymer materials.
- 4D Medicine is valued at approximately $17.8M as of Oct 2026 (last reported valuation).
- It has raised $6.5M; the latest was Later Stage VC ($4.0M) in Dec 2025.
- Notable investors include Innovate UK, SFC Capital, Mercia Ventures, Mercia Asset Management, Midlands Engine Investment Fund — 10 tracked in total.
- Status: Privately Held (backing).
Last reported valuation
LOW confidence$17.8M
4D Medicine's last reported valuation, Dec 2025. Nothing priced has surfaced since.
Free account
More of 4D Medicine with a free account
- ·Watch 4D Medicine: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
No rounds on record
No funding rounds for 4D Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About 4D Medicine
Manufacturer of degradable, implantable medical devices made from novel photopolymer materials. The company is taking a range of devices through regulatory clearance with the FDA(Food and Drug Administration)) before commercial launch, helping medical device suppliers provide patients with resorbable medical devices that help optimize outcomes in applications such as musculoskeletal surgery, soft tissue repair, and drug delivery.
- Sector
- Materials and Resources
- HQ
- Nottingham, United Kingdom
- Founded
- 2018
- Employees
- 11
- Website
- 4dmedicine.co.uk/
- Ownership
- Privately Held (backing)